The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research

Background: We report on the establishment of a web-based Cancer Epidemiology Descriptive Cohort Database (CEDCD). The CEDCD's goals are to enhance awareness of resources, facilitate interdisciplinary research collaborations, and support existing cohorts for the study of cancer-related outcomes. Methods: Comprehensive descriptive data were collected from large cohorts established to study cancer as primary outcome using a newly developed questionnaire. These included an inventory of baseline and follow-up data, biospecimens, genomics, policies, and protocols. Additional descriptive data extracted from publicly available sources were also collected. This information was entered in a searchable and publicly accessible database. We summarized the descriptive data across cohorts and reported the characteristics of this resource. Results: As of December 2015, the CEDCD includes data from 46 cohorts representing more than 6.5 million individuals (29% ethnic/racial minorities). Overall, 78% of the cohorts have collected blood at least once, 57% at multiple time points, and 46% collected tissue samples. Genotyping has been performed by 67% of the cohorts, while 46% have performed whole-genome or exome sequencing in subsets of enrolled individuals. Information on medical conditions other than cancer has been collected in more than 50% of the cohorts. More than 600,000 incident cancer cases and more than 40,000 prevalent cases are reported, with 24 cancer sites represented. Conclusions: The CEDCD assembles detailed descriptive information on a large number of cancer cohorts in a searchable database. Impact: Information from the CEDCD may assist the interdisciplinary research community by facilitating identification of well-established population resources and large-scale collaborative and integrative research. Cancer Epidemiol Biomarkers Prev; 25(10); 1392–401. ©2016 AACR.

[1]  Eric Boerwinkle,et al.  Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts. , 2015, American journal of epidemiology.

[2]  W. Riley,et al.  Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.

[3]  J. Manson,et al.  Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. , 2012, Blood.

[4]  John D Potter,et al.  Toward Rigorous Data Harmonization in Cancer Epidemiology Research: One Approach. , 2015, American journal of epidemiology.

[5]  D. Altshuler,et al.  Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer , 2005, PLoS genetics.

[6]  J Jack Lee,et al.  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Lawler,et al.  Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box? , 2015, Public Health Genomics.

[8]  Eduardo L. Franco,et al.  Making Prospective Registration of Observational Research a Reality , 2014, Science Translational Medicine.

[9]  Eric Boerwinkle,et al.  Translational Genomics is Not a Spectator Sport: A Call to Action , 2012, Genetic epidemiology.

[10]  J. Silverman To register or not to register , 2015, Lab Animal.

[11]  J. Ioannidis,et al.  Transforming Epidemiology for 21st Century Medicine and Public Health , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[13]  Graham A. Colditz,et al.  Merging and emerging cohorts: Not worth the wait , 2007, Nature.

[14]  Geoffrey S. Tobias,et al.  Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. , 2009, American journal of epidemiology.

[15]  A. Wägner,et al.  Fertility is reduced in women and in men with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium (T1DGC) , 2014, Diabetologia.

[16]  M. Pike,et al.  A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) , 2006, Breast Cancer Research.

[17]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[18]  M. Pike,et al.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. , 2014, Journal of the National Cancer Institute.

[19]  Adam S. Kibel,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007 .

[20]  M. Khoury,et al.  A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. , 2015, JAMA.

[21]  M. Bracken Preregistration of epidemiology protocols: a commentary in support. , 2011, Epidemiology.

[22]  J. Ioannidis,et al.  Nested Randomized Trials in Large Cohorts and Biobanks: Studying the Health Effects of Lifestyle Factors , 2008, Epidemiology.

[23]  Michael S. Lauer,et al.  Time for a creative transformation of epidemiology in the United States. , 2012, JAMA.

[24]  J. Potter Epidemiology informing clinical practice: from bills of mortality to population laboratories , 2005, Nature Clinical Practice Oncology.

[25]  J. Ioannidis,et al.  Registering diagnostic and prognostic trials of tests: is it the right thing to do? , 2014, Clinical chemistry.

[26]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010, American journal of epidemiology.